Luis Carlos López Romero

MD, PhD. Nephrologist Hospital General Universitario de Valencia.

[Jonathan Chávez @JonathanNefro]

En hemodiálisis, realizar sesiones de >4:00hrs, comparado a <3:15hrs; se asoció a ↓27% y ↓19% el riesgo de morir y de hospitalizarse, respectivamente

Kidney Int Rep 2026
https://t.co/kNV4gmtRzJ

[Dr. LUIS D'MARCO @luisgerardodg]

Todos invitados a las III Jornadas del
Grupo de Trabajo e Investigación
en Enfermedades Cardiorrenales
y Metabólicas @SVNefro @SENefrologia @prensaUCHCEU @CienciaUCHCEU @Nefro_LaFe @irisvibo @davasrodriguez @mapefer3 @reque_javier @LillyObesityInt @BoehringerES @LcLopezR

[ASN Publications @asnpublications]

A randomized controlled trial in #ASNJASN finds that adjuvant thiazide improved diuretic response more than loop dose increased in patients with acute heart failure and diuretic resistance. Read more: https://t.co/QLFbBJNvKj

[Luis Carlos López Romero @LcLopezR]

Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial - The Lancet https://t.co/ozXMJLFycj

[Luis Carlos López Romero @LcLopezR]

@mapefer3 @NDTsocial @IISLaFe @Nefro_LaFe Gran trabajo !!! @mapefer3

[American Society of Pediatric Nephrology @ASPNeph]

‘Inside CKD’ Multinational-microsimulation Modelling Insights into the Increasing CKD Burden @KIReports
#openaccess

https://t.co/LLt7CzCeDe

[S.E.N. Nefrología @SENefrologia]

Validación multicéntrica de la fórmula Kidney Failure Risk Equation (KFRE) en pacientes españoles con enfermedad renal crónica avanzada https://t.co/aa8L4mc42J en #RevistaNefrología @DrMontomoli @SaraPikasso

[Medscape @Medscape]

Is Universal Healthcare a Realistic Ask for Europeans?
https://t.co/osDW6eLMhs

[Brendon Neuen @brendonneuen]

New in CJASN 📢

Our meta-analysis of 66 CKD trials shows both acute & chronic GFR slope independently predict clinical outcomes

Findings support 3-year total slope as the optimal surrogate endpoint for CKD trials

@asnpublications: https://t.co/wqDIt7B194

[JASN_News @JASN_News]

Torsemide is proposed to have clinically important pharmacokinetic and pharmacodynamic advantages over furosemide. This study found no meaningful pharmacokinetic/pharmacodynamic advantages for torsemide versus furosemide. https://t.co/JCyaecBiAS
@ClevelandClinic
@CleClinicMD
@fperrywilson
@dhekidney

[JASN_News @JASN_News]

Predialysis nephrology care and KRT-directed education (KDE) are essential for incident home dialysis use. This study found that disparities in predialysis nephrology care were significantly associated with lower home dialysis use among Hispanic and Black individuals. https://t.co/PYIfdCyLaZ

[Jonathan Chávez @JonathanNefro]

En hipertensión arterial, clortalidona, comparado a hidroclorotiazida, no fue superior en la prevención de ninguno de los eventos renales posterior a un seguimiento de 2.4 años

Ensayo clínico DCP

JAMA Network Open 2024
10.1001/jamanetworkopen.2024.49576

[Jonathan Chávez @JonathanNefro]

La estimación de la proteinuria con el cociente de proteínas/creatinina urinaria es, prácticamente perfecta, al compararlo con la recolección de 24h (AUC 0.95), certeza independiente a la función renal

Cohorte TUNARI

BMC Nephrology 2024
https://t.co/han2kjfMjR

[AJKD @AJKDonline]

The December 2024 issue is now available: https://t.co/8RS5sWsh39

Highlights:
- Cumulative Blood Pressure and CKD
- Kidney Function and Cancer Risk
- Cryoglobulin-Induced Nephropathy
- Core Curriculum: Viral Nephropathies
- Genetic Testing in Kidney Diseases: Special Report

[Daily Dose of Medicine @MRCEMPREP]

🚑 You’re the Doctor:
A 25-year-old marathon runner collapses at the finish line. Bystanders say he was confused and agitated before collapsing. On arrival:
•BP: 88/60 mmHg
•HR: 145 bpm
•Temp: 41°C (105.8°F)
•RR: 30/min
•Skin: Hot, dry, no sweating.

What’s your next step? 🩺

A. IV fluids and antipyretics 🌡️
B. Rapid sequence intubation 🛏️
C. Ice-water immersion 🧊
D. Administer adrenaline 💉
E. CT brain to rule out stroke 🧠

👇 Comment your answer & reasoning!

#MedTwitter #FOAMed #EmergencyMedicine #MedicalEducation #MedStudentTwitter #DoctorLife #HeatStroke #CriticalCare

[ASN Publications @asnpublications]

Albuminuria testing is an easy way to identify, early on, a higher risk of cardiovascular and kidney morbidity and mortality in patients at-risk. This study found that general practitioners (GPs) were aware of guideline recommendations to screen for albuminuria in patients with diabetes and hypertension but had difficulty interpreting the results. https://t.co/r40Vs05ShV

[AJKD @AJKDonline]

#KDOQI Commentary on @goKDIGO 2024 Clinical Practice Guideline for Evaluation & Management of CKD

https://t.co/TXj3ipu6lP (FREE)

@NishaKidneyDoc @KCavanaugh_MD @Delgadockdny @estrella_khrc @cybeleg1 @HollyMarieMD @WendyStPeter002 @KatherineTuttl8 @jwilliamMD @nkf @NKF_NephPros

[Jonathan Chávez @JonathanNefro]

Dejemos de suplementar vitamina D (cole/ergocalciferol) en personas con enfermedad renal crónica. No tiene efectos clínicos importantes cardiovasculares, óseos o inmunes.

Más cosas en contra en esta excelente revisión 👇🏼

#ISNyoung

CKJ 2024
https:/doi.org/10.1093/ckj/sfae227

[María Peris @mapefer3]

Excited to share our new study on inflammation in HD patients! 🔥 Using metabolomics & LASSO, we found 🔑 differences in autophagy, arginine metab., microbiota & mitochondrial function, etc.🔍 🧪#Hemodialysis #Inflammation #metabolomics @MDPIOpenAccess
https://t.co/XM8Smi7dPg

[Luis Carlos López Romero @LcLopezR]

Our study on adult patients with X-linked hypophosphatemia may offer valuable insights into the natural progression in adults, which can aid in better clinical management. Here we show our results. @jbroseta @juliohe41662387 @SVNefro https://t.co/boODeEnKOd